ORGANIC
LETTERS
2001
Vol. 3, No. 9
1379-1381
cis-Vinylphosphonates and
1,3-Butadienylphosphonates by
Zirconation of 1-Alkynylphosphonates
Abed Al Aziz Quntar† and Morris Srebnik*
Department of Medicinal Chemistry and Natural Products, School of Pharmacy,
Hebrew UniVersity in Jerusalem, Jerusalem 91120, Israel
Received February 21, 2001
ABSTRACT
Addition of “zirconocene” to 1-alkynylphosphonates gives three-membered zirconacylces that can be hydrolyzed to cis-vinylphosphonates or
further reacted with alkynes/hydrolysis to give substituted (Z,E)- and (E,E)-1,3-butadienylphosphonates.
Although 1-alkynylphosphonates have been known since
1957 and their synthesis was developed in the 1960s,1
addition reactions of organometallics remain relatively
unexplored and include syn addition of organocuprates to
1-alkynylphosphonates to give 2,2-disubstituted vinylphos-
phonates,2 reaction of R-stannylated phosphonates with
aldehydes to give E/Z mixtures of 1,2-disubstituted vinyl-
phosphontaes,3 anti hydrotelluration of 1-alkynylphos-
phonates,4 Heck reactions using aryldiazonium salts,5 R-lithi-
ation of â-oxy or â-thio vinylphosphontes,6 NaH-catalyzed
olefination of benzenesulfinylmethylphosphonates,7 and ad-
dition of sodium organyl chalcogenolates to 1-alkynylphos-
phonates.8 These reactions provide access to 1-alkenylphos-
phonates that are very useful compounds for organic
transformations9 and for the synthesis of biologically active
compounds.10 We have recently started to investigate the
addition of organometallic reagents to 1-alkynylphosphon-
ates. Thus, we have discovered that the hydroboration of
1-alkynylphosphonates can be controlled to place boron on
either C1 or C2 of the triple bond by proper use of base,
(8) Braga, A. L.; Alves, E. F.; Silveira, C. C.; Andrade de, L. H.
Tetrahedron Lett. 2000, 41, 161.
(9) For a recent review, see: (a) Minami I, T.; Motoyoshiya, J. Synthesis
1992, 333. Selected recent reactions of vinylphosphonates include the
following. Aziridination: (b) Kim, D. Y.; Rhie, D. Y. Tetrahedron 1997,
53, 13603. Epoxidation: (c) Cristau, H.-J.; Mbianda, X. Y.; Geze, A.; Beziat,
Y.; Gasc, M.-B. J. Organomet. Chem. 1998, 571, 189. Organocuprate
addition: (d) Afarinkia, K.; Binch, H. M.; Modi, C. Tetrahedron Lett. 1998,
39, 7419. C-glycosylation, (e) Junker, H.-D.; Fessner, W.-D. Tetrahedron
Lett. 1998, 39, 269.
† Affiliated with the David R. Bloom Center for Pharmaceutics at the
Hebrew University in Jerusalem.
(1) Iorga, B.; Eymery, F.; Carmichael, D.; Savignac, P. Eur. J. Org.
Chem. 2000, 3103.
(2) (a) Cristau, H.-J.; Mbianda, X. Y.; Beziat, Y.; Gasc, M.-B. J.
Organomet. Chem. 1997, 529, 301. (b) Gil, J. M.; Oh, D. Y. J. Org. Chem.
1999, 64, 2950.
(3) Mimouni, N.; About-Jaudet, E.; Collignon, N.; Savignac, Ph. Synth.
Commun. 1991, 21, 2341.
(4) Jang, W. B.; Oh, D. Y.; Lee, C.-W. Tetrahedron Lett. 2000, 41, 5103.
(5) Brunner, H.; Le Cousturier de Courcy, N.; Geneˆt, J.-P. Synlett 2000,
210.
(6) Kouno. R.; Okauchi, T.; Nakamura, M.; Ichikawa, J.; Minami, T. J.
Org. Chem. 1998, 63, 6239.
(10) As intermediates in drugs or biological investigative compounds:
(a) Harnden, M. R.; Parkin, A.; Parratt, M. J.; Perkins, R. M. J. Med. Chem.
1993, 36, 1343. (b) Smeyers, Y. G.; Romero-Sanchez, F. J.; Hernandez-
Laguna, A.; Fernandez-Ibanez, N.; Galvez-Ruano, E.; Arias-Perez, S. J.
Pharm. Sci. 1987, 76, 753. (c) Megati, S.; Phadtare, S.; Zemlicka, J. J.
Org. Chem. 1992, 57, 2320. (d) Lazrek, H. B.; Rochdi, A.; Khaider, H.;
Barascut, J. L.; Imbach, J. L.; Balzarini, J.; Witvrouw, M.; Pannecouque,
C.; De Clerq, E. Tetrahedron 1998, 54, 3807. (e) Smith, P. W.; Chamiec,
A. J.; Chung-G.; Cobley, K. N.; Duncan, K.; Howes, P. D.; Whittington,
A. R.; Wood, M. R. J. Antibiot. Tokyo 1995, 4 8, 73. Agrochemicals: (e)
Chance, L. H.; Moreau, J. P. U.S. Patent 3910886, 1975.
(7) Shen, Y.; Jiang, G.-F. Synthesis 2000, 99.
10.1021/ol0157454 CCC: $20.00 © 2001 American Chemical Society
Published on Web 03/21/2001